OR WAIT null SECS
April 08, 2021
In an unpredictable world, international life sciences collaborations can lead to misunderstandings and enforcement challenges, making an effective dispute resolution mechanism an essential risk management tool.
March 23, 2021
Assessing the implications for the pharma industry of the America Rescue Plan Act of 2021, which provides nearly two trillion dollars in funding for various government programs, including many related to public health.
March 22, 2021
Mitigating potential risk for stakeholders in light of latest Sunshine Act developments.
March 11, 2021
Treat patents as strategic business assets and build an IP portfolio.
Disputes over mRNA-related patents are poised to persist.
Fighting the pandemic with joint projects and IP sharing.
March 09, 2021
Exploring practical points to further understand and strengthen quality culture.
February 19, 2021
Cybersecurity vulnerabilities embedded in AI and machine learning pose significant litigation risks as life sciences companies move to digital technologies.
February 11, 2021
Pharma manufacturers may need to upgrade their coupon programs to accommodate for the emergence of copay accumulators and related benefit mechanisms.
February 10, 2021
How the unfolding of notable infringement claim could alter commercial approaches for players in wider CBD treatment field.
